BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 32349546)

  • 21. The expression of long non coding RNA genes is associated with expression with polymorphisms of HULC rs7763881 and MALAT1 rs619586 in hepatocellular carcinoma and HBV Egyptian patients.
    Motawi TMK; El-Maraghy SA; Sabry D; Mehana NA
    J Cell Biochem; 2019 Sep; 120(9):14645-14656. PubMed ID: 31009106
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of polymorphisms in MALAT1 with risk of coronary atherosclerotic heart disease in a Chinese population.
    Wang G; Li Y; Peng Y; Tang J; Li H
    Lipids Health Dis; 2018 Apr; 17(1):75. PubMed ID: 29631611
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of MALAT1 and PVT1 Variants, Expression Profiles and Target miRNA-101 and miRNA-186 with Colorectal Cancer: Correlation with Epithelial-Mesenchymal Transition.
    Radwan AF; Shaker OG; El-Boghdady NA; Senousy MA
    Int J Mol Sci; 2021 Jun; 22(11):. PubMed ID: 34200314
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long Noncoding RNA MALAT1 Promotes Colorectal Cancer Progression by Acting as a ceRNA of miR-508-5p to Regulate RAB14 Expression.
    Zhang C; Yao K; Zhang J; Wang C; Wang C; Qin C
    Biomed Res Int; 2020; 2020():4157606. PubMed ID: 33344634
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long noncoding RNA MALAT1 mediates stem cell-like properties in human colorectal cancer cells by regulating miR-20b-5p/Oct4 axis.
    Tang D; Yang Z; Long F; Luo L; Yang B; Zhu R; Sang X; Cao G; Wang K
    J Cell Physiol; 2019 Nov; 234(11):20816-20828. PubMed ID: 31012108
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rs11655237 polymorphism of LINC00673 affects the prognosis of cervical cancer by interfering with the interaction between LINC00673 and microRNA-1231.
    Zhu W; Li L; Li D
    J Cell Physiol; 2020 Nov; 235(11):8155-8166. PubMed ID: 31957869
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Elucidation of the Mechanism by Which a
    Weng K; Luo M; Dong D
    Genet Test Mol Biomarkers; 2020 Aug; 24(8):467-477. PubMed ID: 32700984
    [No Abstract]   [Full Text] [Related]  

  • 28. Prognostic and predictive value of long non-coding RNA GAS5 and mircoRNA-221 in colorectal cancer and their effects on colorectal cancer cell proliferation, migration and invasion.
    Liu L; Meng T; Yang XH; Sayim P; Lei C; Jin B; Ge L; Wang HJ
    Cancer Biomark; 2018; 22(2):283-299. PubMed ID: 29630521
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A variant in microRNA-196a2 is not associated with susceptibility to and progression of colorectal cancer in Chinese.
    Chen H; Sun LY; Chen LL; Zheng HQ; Zhang QF
    Intern Med J; 2012 Jun; 42(6):e115-9. PubMed ID: 21241442
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Associations of MALAT1 and its functional single nucleotide polymorphisms with cancer.
    Cao L; Yan G; Yu S; Li F; Su Z; Hou X; Xiao J; Tian T
    Pathol Res Pract; 2022 Aug; 236():153988. PubMed ID: 35759938
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Contribution of microRNA-149, microRNA-146a, and microRNA-196a2 SNPs in colorectal cancer risk and clinicopathological features in Tunisia.
    Chayeb V; Mahjoub S; Zitouni H; Jrah-Harzallah H; Zouari K; Letaief R; Mahjoub T
    Gene; 2018 Aug; 666():100-107. PubMed ID: 29715515
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Polymorphism rs2682818 in miR-618 is associated with colorectal cancer susceptibility in a Han Chinese population.
    Chen Y; Du M; Chen W; Zhu L; Wu C; Zhang Z; Wang M; Chu H; Gu D; Chen J
    Cancer Med; 2018 Apr; 7(4):1194-1200. PubMed ID: 29533012
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The association of a single-nucleotide variant in the microRNA-146a with advanced colorectal cancer prognosis.
    Santos JSD; Zunta GL; Negrini AB; Ribeiro MSG; Martinez CAR; Ribeiro ML; Lourenço GJ; Ortega MM
    Tumour Biol; 2020 May; 42(5):1010428320923856. PubMed ID: 32438863
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aberrant expression of lncRNA MALAT1 modulates radioresistance in colorectal cancer in vitro via miR-101-3p sponging.
    Guo J; Ding Y; Yang H; Guo H; Zhou X; Chen X
    Exp Mol Pathol; 2020 Aug; 115():104448. PubMed ID: 32380053
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A functional polymorphism in lnc-LAMC2-1:1 confers risk of colorectal cancer by affecting miRNA binding.
    Gong J; Tian J; Lou J; Ke J; Li L; Li J; Yang Y; Gong Y; Zhu Y; Zhang Y; Zhong R; Chang J; Miao X
    Carcinogenesis; 2016 May; 37(5):443-51. PubMed ID: 26905585
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of extracellular LncRNA-SNHG14/miRNA-3940-5p/NAP12 mRNA in colorectal cancer.
    Matboli M; Shafei AE; Ali MA; El-Din Ahmed TS; Naser M; Abdel-Rahman T; Anber N; Ali M
    Arch Physiol Biochem; 2021 Dec; 127(6):479-485. PubMed ID: 31397210
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association between microRNA genetic variants and susceptibility to colorectal cancer in Chinese population.
    Hu X; Li L; Shang M; Zhou J; Song X; Lu X; Wang J; Ying B; Wang L
    Tumour Biol; 2014 Mar; 35(3):2151-6. PubMed ID: 24136745
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MALAT1 Is Associated with Poor Response to Oxaliplatin-Based Chemotherapy in Colorectal Cancer Patients and Promotes Chemoresistance through EZH2.
    Li P; Zhang X; Wang H; Wang L; Liu T; Du L; Yang Y; Wang C
    Mol Cancer Ther; 2017 Apr; 16(4):739-751. PubMed ID: 28069878
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High expression of lncRNA MALAT1 suggests a biomarker of poor prognosis in colorectal cancer.
    Zheng HT; Shi DB; Wang YW; Li XX; Xu Y; Tripathi P; Gu WL; Cai GX; Cai SJ
    Int J Clin Exp Pathol; 2014; 7(6):3174-81. PubMed ID: 25031737
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long Noncoding RNA
    Li Y; Zhang Z; Yang Y; Ma J
    Genet Test Mol Biomarkers; 2020 Jan; 24(1):38-46. PubMed ID: 31940242
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.